A Randomized Study of Gemtuzumab Ozogamicin (GO) With Daunorubicine and Cytarabine in Untreated Acute Myeloid Leukemia (AML) Aged of 50-70 Years Old
Clinical trial NCT00927498 · COMPLETED
Trial details
- NCT number
- NCT00927498
- Sponsor
- Acute Leukemia French Association
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2011-07-01
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.